INAB - IN8bio Inc
1.77
0.050 2.825%
Share volume: 46,458
Last Updated: 03-09-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$1.72
0.05
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 03-13-2025 | 05-07-2025 | 11-06-2025 | |
| Cash flow financing | -277.000 K | 3.379 M | -105.000 K | 11.187 M | 3.893 M | 989.000 K | |
| Other financing cash flows | -188.000 K | -149.000 K | -394.000 K | -38.000 K | 158.000 K | -123.000 K | |
| Cash flow | -8.267 M | -2.795 M | 0.000 | 7.126 M | 771.000 K | 0.000 | |
| Net income | -8.562 M | -8.629 M | -6.018 M | -7.228 M | -5.550 M | -3.854 M | |
| Depreciation | 239.000 K | 234.000 K | 252.000 K | 251.000 K | 256.000 K | 244.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -71.000 K | -83.000 K | 0.000 | -33.000 K | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | -21.000 K | -62.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 50.000 K | 21.000 K | 0.000 | 33.000 K | 0.000 | 0.000 | |
| Cash Change | -8.267 M | -2.795 M | -6.216 M | 7.126 M | 771.000 K | -2.535 M |